Want to join the conversation?
Rich Valera of Needham & Co. asks about Opex trends going into next year. $ADTN said in 2Q16, it undertook some additional development work for some specific customers. $ADTN added some contract-based headcount which will close out at this year-end. Going forward, these expenses will be gone and headcount will not be added.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?